AONM WEBINAR SERIES
DISCLAIMER: THIS SITE DOES NOT PROVIDE MEDICAL ADVICE
The information on this webpage and these webinars is intended for educational and informative purposes only and is not intended as a substitute for medical or professional advice, diagnosis or treatment. Always seek the advice of your doctor or other qualified health care provider with regards to any questions you may have regarding a medical condition or treatment before undertaking a health care regimen. Never disregard or delay seeking professional medical advice because of information you have read or seen on this website. The opinions stated in these webinars are those of the people speaking and not necessarily of AONM.
Advancing Research in Gestational Lyme Disease: Biobank Establishment and Study Development
Professor Gilbert is Editor of Borrelia Burgdorferi – Methods and Protocols. “Cutting-edge and comprehensive, Borrelia burgdorferi: Methods and Protocols encompasses a wide range of techniques and caters to scientists from various disciplines and career stages, such as cell and molecular biologists, statisticians, and clinical researchers.” (https://link.springer.com/book/10.1007/978-1-0716-3561-2#about-this-book).
Prof. Robert Bransfield
Dr. Rosalie Greenberg
Download PresentationDr. Charlotte Mao
Download PresentationMicrobes and Mental Illness: Past, Present, and Future
Professor John Lambert
Dr. Minha Rajput-Ray
Professor Leona Gilbert
Mr. Kunal Garg
Expert Panel Roundtable: Advancements in CD Cell, Lyme, and Coinfection Research
Note: Presentation slides are unavailable for the time being due to research papers being submitted for publication
Professor Gilbert is Editor of Borrelia Burgdorferi – Methods and Protocols. “Cutting-edge and comprehensive, Borrelia burgdorferi: Methods and Protocols encompasses a wide range of techniques and caters to scientists from various disciplines and career stages, such as cell and molecular biologists, statisticians, and clinical researchers.” (https://link.springer.com/book/10.1007/978-1-0716-3561-2#about-this-book).
Prof. Craig Shimasaki
The Autoimmune Brain Panel™ & Neurological Symptoms
Dr. Nancy O’Hara
Demystifying PANS/PANDAS Part 2, with Extended Q&As
Professor Gilbert is Editor of Borrelia Burgdorferi – Methods and Protocols. “Cutting-edge and comprehensive, Borrelia burgdorferi: Methods and Protocols encompasses a wide range of techniques and caters to scientists from various disciplines and career stages, such as cell and molecular biologists, statisticians, and clinical researchers.” (https://link.springer.com/book/10.1007/978-1-0716-3561-2#about-this-book).
Revolutionizing Lyme Disease Management: Predictive Modelling and Diagnostic Innovations Unveiled
Professor Gilbert is Editor of Borrelia Burgdorferi – Methods and Protocols. “Cutting-edge and comprehensive, Borrelia burgdorferi: Methods and Protocols encompasses a wide range of techniques and caters to scientists from various disciplines and career stages, such as cell and molecular biologists, statisticians, and clinical researchers.” (https://link.springer.com/book/10.1007/978-1-0716-3561-2#about-this-book).
From Detection to Treatment: Exploring Viral Testing, Reactivation, and Therapy
Demystifying PANS/PANDAS: A Functional Medicine Guide on Basal Ganglia Encephalitis
Dr. Armin Schwarzbach
Dr. Sarah Myhill
Professor Leona Gilbert
Zhaneta Misho
Gilian Crowther MA
Decemeber Roundtable – Delving deeper on testing, therapies and management strategies for chronic infections
Dr. Armin Schwarzbach
Dr. Sarah Myhill
Professor Leona Gilbert
Zhaneta Misho
Gilian Crowther MA
Aonm Roundtable Discussion on testing, therapies and management strategies for chronic infections
Reset Eating: Taking Control of Your Health by Turning Food into Powerful Medicine
Dr. Armin Schwarzbach
Long Covid Pathogen Reactivation: Testing and Therapeutic Options – Follow Up Q&As
Long Covid Pathogen Reactivation: Testing and Therapeutic Options
Breathe Easy: Maximizing the Benefits of Oxygen for Better Health and Wellness
Julia Behrens
LOST IN LYME: The Therapeutic Use of Plants in Supporting People with Lyme Disease
Dr. Armin Schwarzbach
Overview on the Occurrence of Lyme and Coinfections over the Pandemic
Prof. Robert Bransfield
The Convergence of Two Pandemics: Lyme Disease and COVID-19
Scientific Evidence to Support the Use of Phytochemicals for Lyme Borreliosis
Prof. Craig Shimasaki
The Rise in Other Infections Post-COVID and our Immune Response: What impact can these have on an increase in autoimmune encephalitis?
Toxiplex – A direct mycotoxin detection assay for human serum/plasma
Advanced Mitochondrial Testing and Potential Therapies
Long COVID from a Clinical Perspective
FOLLOW UP Q&A
The Growing Evidence Between Infections and Cancer (Part 2)
The Growing Evidence Between Infections and Cancer (Part 1)
The Potential Connection of Borrelia Infection and Breast Cancer
Dr Craig Shimasaki
Can Infections Really Trigger Autoimmune Neuropsychiatric Disorders?
Mitochondrial Magic – Tips for improving mitochondrial health
Long COVID: A Post-Infectious Autoimmune Syndrome, Understanding Commonalities and Biological Clues from Other Post-Infectious Autoimmune Syndromes
Chronic Lyme Disease and Chronic COVID-19
“Fixing the Bite”: Diagnosing and treating dental occlusal disorders
The Importance of diagnosis and staging in managing Craniocervical Syndromes (Part 2 – includes lengthy Q & A)
The Importance of diagnosis and staging in managing Craniocervical Syndromes
Prof. Francis Smith MD, FFRRCSI, FRCR, FRSC (Ed), FRCP (Ed), FFSEM
PDF Presentation Part 1PDF Presentation Part 2PDF Presentation Part 3The Craniocervical Junction, Hypermobility and Upright MRI
Chris Woollams, M.A. Founder of CancerActive
Rebuilding the Microbiome: A Vital Approach in the Treatment of Cancer and Chronic Illness
Dr. Sam Yanuck
Therapies for Autoimmune Encephalopathies
Dr. Craig Shimasaki
The Links between Lyme Disease and Autoimmune Encephalopathy and Basal Ganglia Encephalitis (BGE)
Prof. Dr. Katharina Pachmann
Apoptosis efficency of natural agents and an overview of therapy-relevant characteristics of circulating cancer cells
Chris Woollams MA (Oxon, Biochemistry)
The Benefits of Complementary and Integrative Medicine in the Field of Oncology
The Effect of Natural Therapies and CTC (Circulating Cancer Cells) Testing on Patients with Cancer
Dr. Joseph Jemsek
Questions and Answer Session: Lyme Borreliosis complex and COVID-19. How do they interact?
Dr. Sarah Myhill
Questions and Answer Session: Interconnections between M.E. and COVID, and effective therapies. Following on from the earlier webinar in this series
Dr. Robert Bransfield
Questions and answers following the earlier “Tale of Two Pandemics: Lyme Disease and COVID-19” webinar
Dr. Armin Schwarzbach
SARS-CoV-2 Testing Part 2
Dr. Richard Horowitz
PDF of presentationThree novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials
by Richard I.Horowitzab, Phyllis R.Freeman
Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases Horowitz, R.I., Freeman P, Bruzzese, J
COVID-19: Prevention, Diagnosis and Treatment Options
Dr. Jodie Dashore
Interconnections between COVID-19, PANS/PANDAS and biotoxin illness
A Tale of Two Pandemics Lyme Disease and COVID-19
Dr. Joseph Jemsek
Lyme Borreliosis Complex and COVID-19. How Do They Interact?
International Awareness Day Special 2020
Drs. Gilbert and Schwarzbach
SARS-CoV-2 (COVID-19) Testing Part 2: Introducing the First Multiplex ELISA to Incorporate Three Immunoglobulins
Jenna Luche-Thayer
Jenna Luché-Thayer on What are the Human Rights Challenges Around COVID-19
Dr. Armin Schwarzbach
Dr. Armin Schwarzbach on his research and approach to COVID-19 testing
The Association Between Hypercoagulation, MCAS, and Infections
Dr. Schwarzbach discusses the important and underrecognised links between infections and hypercoagulation (“sticky blood”), mast cell overreactivity (mast cell activation syndrome is one name for this – MCAS). Dr. Schwarzbach specialises in testing for tick-borne infections, but he will also be covering a wider range of pathogens, including viruses.
Personalised Testing of Natural Substances in Order to Support Cancer Cell Apoptosis
Prof. Dr. Med. Katharina Pachmann discusses the methods that her laboratory uses, and their findings.
PROF. DR. MED. KATHARINA PACHMANN is the founder of the Maintrac system of identifying circulating cancer cells in a “liquid biopsy”, and runs the Maintrac laboratory in Bayreuth, Germany, together with Dr. Ulrich Pachmann and a staff of 45. As both a medical doctor and research scientist, she has been conducting studies in this field and refining related techniques for over two decades, and has authored over a hundred scientific publications on the technique (https://aonm.org/scientific-articles-and-studies/)
She received her PhD from the Institute for Haematology at the Society for Radiological Research, Munich, and worked as the Head of the Department of Experimental Haematology and Oncology, Friedrich Schiller-University, Jena, for many years. She is a visiting scientist at the University Clinic, Graz, Austria, and has also served in the same capacity at MD Anderson Cancer Center Houston Texas Section of Molecular Hematology and Therapy.
PANDAS/PANS and Other Infection-Triggered Autoimmune Encephalopathies: Interpretation of the Cunningham Panel Results
Dr. Craig D. Shimasaki, PhD, MBA is President & CEO Moleculera Labs, Inc.
PANS and PANDAS are infection-induced autoimmune conditions that disrupt a patient’s normal neurologic functioning. PANS and PANDAS can include a variety of symptoms, such as OCD, motor tics, anxiety, irritability, hyperactivity, sleep disturbances, mood swings, depression, hyperactivity, difficulty concentrating, behavioural regression and urinary problems. This condition can exist in adults too, not just children.
This is the second of three webinars on this topic. In the first webinar Dr. Shimasaki explains the background to the Cunningham Panel and indications for its use. To view the first webinar see below or follow this link https://aonm.org/view-past-webinars/
In this second webinar Dr. Shimasaki will focus on how to interpret the findings, including new study results that substantiate correlations between results and patient symptoms/outcomes.
Moleculera Labs is the only lab in the world to test for autoimmune activity against neuronal targets in the brain that is used by clinics/practitioners across the world to identify encephalitic-type activity called “PANS/PANDAS” in children, and autoimmune encephalopathy in adults. It is characterised by many symptoms that are often considered psychiatric and not given any further biomedical exploration.
NEURO-AUTOIMMUNE CONDITIONS AND HOW TO TEST FOR THEM
Dr. Craig D. Shimasaki, PhD, MBA is President & CEO Moleculera Labs, Inc.
Moleculera Labs is the only lab in the world to test for autoimmune activity against neuronal targets in the brain that is used by clinics/practitioners across the world to identify encephalitic-type activity called “PANS/PANDAS” in children, and autoimmune encephalopathy in adults. It is characterised by many symptoms that are often considered psychiatric and not given any further biomedical exploration. He will explain the use of the Cunningham Panel, how to interpret the results, and its application in therapy. This will be the first of three webinars on this topic
Dr Shimisaki is a scientist with over 33 years of clinical diagnostic and therapeutic R&D experience, starting his career at Genentech. During his tenure he has been involved in the research, development and clinical testing of neuropsychiatric drugs and diagnostics, genetic testing for predisposition to non-familial breast cancer, a gp-120 HIV vaccine, and influenza and RSV diagnostics and therapeutics. He co-founded Moleculera Labs with Dr. Madeleine Cunningham, an autoimmune neurobiology clinical laboratory based upon her 20+ years of research on infection-triggered autoimmune disorders.
His focus has been to translate basic research discoveries into acutely needed medical products for patients who need them. He has led five clinical diagnostic tests through FDA approval process and is a co-inventor on several medical and diagnostic patents. Dr. Shimasaki is an Adjunct Professor at the University of Oklahoma. He has authored and edited two books “The Business of Bioscience: What Goes Into Making a Biotechnology Product” and “Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies.” He received his BS in Biochemistry from University of California at Davis, his PhD in Molecular Biology from the University of Tulsa, and his MBA from Northwestern University, Kellogg School of Business.
IDENTIFYING STEALTH INFECTIONS THAT MAY UNDERLIE ME, FIBROMYALGIA AND OTHER SYNDROMES
Dr. Schwarzbach is Founder and Medical Director at ArminLabs, Augsburg, Germany.
He presented evidence of the different bacterial and viral infections that can lead to syndromes that are often labelled unexplained or psychiatric in nature, and gave insights from his three decades of experience in this field. He explains algorithims for deciding which to test for, and also answered a number of questions in a live Q&A.
Please see https://aonm.org/armin-labs/ for background information on this lab and its tests.
As a Medical Doctor and specialist in laboratory medicine with three decades of experience in clinical medicine and laboratory testing, Dr. Schwarzbach specialises in laboratory medicine in infectiology, microbiology, immunology, hematology, clinical chemistry, endocrinology and gynecological endocrinology.
TESTING CIRCULATING CANCER CELLS, CHEMOSENSITIVITY AND THE EFFECTIVENESS OF NATURAL AGENTS
Professor Dr. med. Katharina Pachmann is the founder of the Maintrac system of identifying circulating cancer cells in a “liquid biopsy”, and runs the Maintrac laboratory in Bayreuth, Germany, together with Dr. Ulrich Pachmann and a staff of 45.
Professor Katharina Pachmann explained how the Maintrac test in Germany tests for circulating cancer cells, the circumstances within which it may be appropriate to use it, and how it tests for the effectiveness of chemotherapeutic as well as natural agents. Please see https://aonm.org/maintrac/
As both a medical doctor and research scientist, she has been conducting studies in this field and refining related techniques for over two decades, and has authored over a hundred scientific publications on the technique (https://aonm.org/scientific-articles-and-studies/).
She received her PhD from the Institute for Haematology at the Society for Radiological Research, Munich, and worked as the Head of the Department of Experimental Haematology and Oncology, Friedrich Schiller-University, Jena, for many years. She is a visiting scientist at the University Clinic, Graz, Austria, and has also served in the same capacity at MD Anderson Cancer Center Houston Texas Section of Molecular Hematology and Therapy.